24 May 2013
Keywords: genentech, hgh, approved, usa, received, approval, market
Article | 21 March 1994
Genentech has received approval to market its recombinant human growth hormone product, Nutropin, for the treatment of short stature caused ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.